{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:54:34Z","timestamp":1762005274235,"version":"build-2065373602"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T00:00:00Z","timestamp":1597708800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.exphem.2020.08.004","type":"journal-article","created":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T02:28:00Z","timestamp":1597285680000},"page":"52-64.e11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Feeder-free and serum-free in vitro assay for measuring the effect of drugs on acute and chronic myeloid leukemia stem\/progenitor cells"],"prefix":"10.1016","volume":"90","author":[{"given":"Hanyang","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jackie E.","family":"Damen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta A.","family":"Walasek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen J.","family":"Szilvassy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali G.","family":"Turhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon A.","family":"Louis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allen C.","family":"Eaves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albertus W.","family":"Wognum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2020.08.004_bib0001","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/S0140-6736(13)62120-0","article-title":"Chronic myeloid leukaemia","volume":"385","author":"Apperley","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.exphem.2020.08.004_bib0002","doi-asserted-by":"crossref","first-page":"e441","DOI":"10.1038\/bcj.2016.50","article-title":"Acute myeloid leukemia: a comprehensive review and 2016 update","volume":"6","author":"De Kouchkovsky","year":"2016","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.exphem.2020.08.004_bib0003","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/315550a0","article-title":"Fused transcript of abl and bcr genes in chronic myelogenous leukaemia","volume":"315","author":"Shtivelman","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2020.08.004_bib0004","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1182\/blood-2011-08-358135","article-title":"Improved survival in chronic myeloid leukemia since the introduction of imatinib therapy: a single-institution historical experience","volume":"119","author":"Kantarjian","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2020.08.004_bib0005","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1126\/science.1062538","article-title":"Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification","volume":"293","author":"Gorre","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.exphem.2020.08.004_bib0006","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nrc3317","article-title":"Pushing the limits of targeted therapy in chronic myeloid leukaemia","volume":"12","author":"O'Hare","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.exphem.2020.08.004_bib0007","doi-asserted-by":"crossref","first-page":"4179","DOI":"10.1182\/blood-2008-07-172007","article-title":"Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry","volume":"113","author":"Juliusson","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2020.08.004_bib0008","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.beha.2018.09.005","article-title":"Is the overall survival for older adults with AML finally improving?","volume":"31","author":"Lancet","year":"2018","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.exphem.2020.08.004_bib0009","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1002\/ijc.30186","article-title":"Survival in patients with acute myeloblastic leukemia in Germany and the United States: major differences in survival in young adults","volume":"139","author":"Pulte","year":"2016","journal-title":"Int J Cancer"},{"key":"10.1016\/j.exphem.2020.08.004_bib0010","first-page":"7","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.exphem.2020.08.004_bib0011","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S0140-6736(98)03030-X","article-title":"Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation","volume":"352","author":"Gratwohl","year":"1998","journal-title":"Lancet."},{"key":"10.1016\/j.exphem.2020.08.004_bib0012","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/sj.leu.2404609","article-title":"Chronic myeloid leukemia stem cells possess multiple unique features of resistance to BCR-ABL targeted therapies","volume":"21","author":"Jiang","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2020.08.004_bib0013","doi-asserted-by":"crossref","first-page":"5565","DOI":"10.1182\/blood-2010-12-327437","article-title":"Persistence of leukemia stem cells in chronic myelogenous leukemia patients in prolonged remission with imatinib treatment","volume":"118","author":"Chu","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2020.08.004_bib0014","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1532\/IJH97.05144","article-title":"Biology of normal and acute myeloid leukemia stem cells","volume":"82","author":"Dick","year":"2005","journal-title":"Int J Hematol"},{"key":"10.1016\/j.exphem.2020.08.004_bib0015","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/ni1080","article-title":"Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity","volume":"5","author":"Hope","year":"2004","journal-title":"Nat Immunol"},{"key":"10.1016\/j.exphem.2020.08.004_bib0016","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1182\/blood-2009-04-215376","article-title":"BCR-ABL enhances differentiation of long-term repopulating hematopoietic stem cells","volume":"115","author":"Schemionek","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2020.08.004_bib0017","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.leukres.2008.11.011","article-title":"In vitro biology of human myeloid leukemia","volume":"33","author":"Mayani","year":"2009","journal-title":"Leuk Res"},{"key":"10.1016\/j.exphem.2020.08.004_bib0018","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1182\/blood-2014-06-581926","article-title":"MicroRNA-486 regulates normal erythropoiesis and enhances growth and modulates drug response in CML progenitors","volume":"125","author":"Wang","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2020.08.004_bib0019","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/leu.2014.245","article-title":"Combined STAT3 and BCR-ABL1 inhibition induces synthetic lethality in therapy-resistant chronic myeloid leukemia","volume":"29","author":"Eiring","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2020.08.004_bib0020","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.stem.2014.08.001","article-title":"SIRT1 activation by a c-MYC oncogenic network promotes the maintenance and drug resistance of human FLT3-ITD acute myeloid leukemia stem cells","volume":"15","author":"Li","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.exphem.2020.08.004_bib0021","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood-2011-01-330019","article-title":"A small molecule screening strategy with validation on human leukemia stem cells uncovers the therapeutic efficacy of kinetin riboside","volume":"119","author":"McDermott","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2020.08.004_bib0022","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/978-1-4939-4011-0_16","article-title":"New mouse models to investigate the efficacy of drug combinations in human chronic myeloid leukemia","volume":"1465","author":"Lin","year":"2016","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.exphem.2020.08.004_bib0023","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.scr.2014.11.007","article-title":"Long term maintenance of myeloid leukemic stem cells cultured with unrelated human mesenchymal stromal cells","volume":"14","author":"Ito","year":"2015","journal-title":"Stem Cell Res"},{"key":"10.1016\/j.exphem.2020.08.004_bib0024","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1182\/blood-2012-02-412890","article-title":"Microenvironmental protection of CML stem and progenitor cells from tyrosine kinase inhibitors through N-cadherin and Wnt-beta-catenin signaling","volume":"121","author":"Zhang","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2020.08.004_bib0025","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/toxsci\/kfg188","article-title":"Application of the CFU-GM assay to predict acute drug-induced neutropenia: an international blind trial to validate a prediction model for the maximum tolerated dose (MTD) of myelosuppressive xenobiotics","volume":"75","author":"Pessina","year":"2003","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.exphem.2020.08.004_bib0026","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.tiv.2008.11.006","article-title":"Application of human CFU-Mk assay to predict potential thrombocytotoxicity of drugs","volume":"23","author":"Pessina","year":"2009","journal-title":"Toxicol in Vitro"},{"key":"10.1016\/j.exphem.2020.08.004_bib0027","doi-asserted-by":"crossref","first-page":"eaan8735","DOI":"10.1126\/scitranslmed.aan8735","article-title":"PP2A inhibition sensitizes cancer stem cells to ABL tyrosine kinase inhibitors in BCR-ABL(+) human leukemia","volume":"10","author":"Lai","year":"2018","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.exphem.2020.08.004_bib0028","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1126\/science.1256337","article-title":"Cord blood expansion: pyrimidoindole derivatives are agonists of human hematopoietic stem cell self-renewal","volume":"345","author":"Fares","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.exphem.2020.08.004_bib0029","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nmeth.2847","article-title":"Identification of small molecules that support human leukemia stem cell activity ex vivo","volume":"11","author":"Pabst","year":"2014","journal-title":"Nat Methods"},{"key":"10.1016\/j.exphem.2020.08.004_bib0030","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/108705719900400206","article-title":"A simple statistical parameter for use in evaluation and validation of high throughput screening assays","volume":"4","author":"Zhang","year":"1999","journal-title":"J Biomol Screen"},{"key":"10.1016\/j.exphem.2020.08.004_bib0031","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.celrep.2019.06.084","article-title":"Integrin-alpha3 is a functional marker of ex vivo expanded human long-term hematopoietic stem cells","volume":"28","author":"Tomellini","year":"2019","journal-title":"Cell Rep"},{"key":"10.1016\/j.exphem.2020.08.004_bib0032","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.stem.2019.09.008","article-title":"Sphingolipid modulation activates proteostasis programs to govern human hematopoietic stem cell self-renewal","volume":"25","author":"Xie","year":"2019","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.exphem.2020.08.004_bib0033","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1038\/leu.2014.44","article-title":"BCL-2 family proteins as 5-azacytidine-sensitizing targets and determinants of response in myeloid malignancies","volume":"28","author":"Bogenberger","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2020.08.004_bib0034","doi-asserted-by":"crossref","first-page":"8637","DOI":"10.18632\/oncotarget.2353","article-title":"Selective JAK2\/ABL dual inhibition therapy effectively eliminates TKI-insensitive CML stem\/progenitor cells","volume":"5","author":"Lin","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.exphem.2020.08.004_bib0035","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1038\/s41598-017-01913-y","article-title":"ALOX5 exhibits anti-tumor and drug-sensitizing effects in MLL-rearranged leukemia","volume":"7","author":"Wang","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.exphem.2020.08.004_bib0036","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.2147\/OTT.S191621","article-title":"Mechanisms of drug resistance in acute myeloid leukemia","volume":"12","author":"Zhang","year":"2019","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.exphem.2020.08.004_bib0037","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12943-016-0571-x","article-title":"Targeting acute myeloid leukemia stem cell signaling by natural products","volume":"16","author":"Siveen","year":"2017","journal-title":"Mol Cancer"},{"key":"10.1016\/j.exphem.2020.08.004_bib0038","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.cell.2018.07.045","article-title":"Small molecules co-targeting CKI\u03b1 and the transcriptional kinases CDK7\/9 control AML in preclinical models","volume":"175","author":"Minzel","year":"2018","journal-title":"Cell"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X20303490?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X20303490?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T08:34:57Z","timestamp":1759566897000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X20303490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":38,"alternative-id":["S0301472X20303490"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2020.08.004","relation":{},"ISSN":["0301-472X"],"issn-type":[{"type":"print","value":"0301-472X"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Feeder-free and serum-free in vitro assay for measuring the effect of drugs on acute and chronic myeloid leukemia stem\/progenitor cells","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2020.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 ISEH -- Society for Hematology and Stem Cells. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}